Researchers
-
Anna Planas Ballvé
Clinical neuropsychiatry and neuropsychology
-
Asunción Ávila
Clinical neuropsychiatry and neuropsychology
Phd -
Dolores Lozano
Clinical neuropsychiatry and neuropsychology
-
Ester Moral Torres
Clinical neuropsychiatry and neuropsychology
-
Irati Zubizarreta
Clinical neuropsychiatry and neuropsychology
Phd -
Joan Bello López
Clinical neuropsychiatry and neuropsychology
Phd -
José Vicente Hervas-garcía
Clinical neuropsychiatry and neuropsychology
Phd -
Juan Bernardo Gómez
Clinical neuropsychiatry and neuropsychology
-
Juan José Mengual
Clinical neuropsychiatry and neuropsychology
-
Laura Gubieras Lillo
Clinical neuropsychiatry and neuropsychology
-
Mª Isabel Gómez Ruiz
Clinical neuropsychiatry and neuropsychology
Phd -
Marta Balagué
Clinical neuropsychiatry and neuropsychology
-
Mercè Leixà
Clinical neuropsychiatry and neuropsychology
-
Mireia Grau
Clinical neuropsychiatry and neuropsychology
-
Monica Prat
Clinical neuropsychiatry and neuropsychology
-
Montse Vacas Moreira
Clinical neuropsychiatry and neuropsychology
-
Nuria Caballol
Clinical neuropsychiatry and neuropsychology
-
Pablo Millet Balance
Clinical neuropsychiatry and neuropsychology
-
Sonia Maria Garcia
Clinical neuropsychiatry and neuropsychology
-
Xavier Cardona
Clinical neuropsychiatry and neuropsychology
Contact the group
Form
Projects
-
Clinical neuropsychiatry and neuropsychology
Researcher
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Cognitive stimulation through board games: a new approach to active aging to improve the daily challenges of users with Multiple Sclerosis,
-
DISTRICT ATTORNEY:
Hospital of Tortosa Verge de la Cinta
-
TYPE E:
PI
-
Clinical neuropsychiatry and neuropsychology
Researcher
- Year 2015
- Hospital General de l'Hospitalet
COPPADIS-15 Cohort of Patients with Parkinson's Disease in Sapain,
-
DISTRICT ATTORNEY:
Spanish Foundation for Parkinson's Research Aid
-
TYPE E:
EPA
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Phase 3, multicenter, randomized, double-blind, double-simulated, active-controlled, and parallel-group study to evaluate the efficacy and safety of orally administered RPC1063 in patients with relapsing multiple sclerosis,
-
DISTRICT ATTORNEY:
Recipes, Inc.
-
TYPE E:
RD2004
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Evaluation of patients' preferences towards the different treatment options for modifying relapsing remitting multiple sclerosis,
-
DISTRICT ATTORNEY:
Roche- Farma SA
-
TYPE E:
EPA
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Evaluation of patients' preferences towards the different treatment options for modifying relapsing remitting multiple sclerosis,
-
DISTRICT ATTORNEY:
Roche- Farma SA
-
TYPE E:
EPA
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Observational, non-interventionist study to evaluate the changes in the quality of life in patients treated with Teriflunomide in routine clinical practice,
-
DISTRICT ATTORNEY:
Sanofi Aventis, SA,
-
TYPE E:
EPA
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
COPPADIS-15 Cohort of Patients with Parkinson's Disease in Spain
-
DISTRICT ATTORNEY:
Spanish Foundation for Aid to Parkinson's Research
-
TYPE E:
EPA
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Cognitive stimulation through board games: a new approach to active aging to improve the daily challenges of users with Multiple Sclerosis,
-
DISTRICT ATTORNEY:
Hospital of Tortosa Verge de la Cinta
-
TYPE E:
PINE TREE
-
- Year 2015
- L'Hospitalet General Hospital
COPPADIS-15 Cohort of Patients with Parkinson's Disease in Sapain,
-
DISTRICT ATTORNEY:
Spanish Foundation for Aid to Parkinson's Research
-
TYPE E:
EPA
-
Clinical neuropsychiatry and neuropsychology
Researcher
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
Retrospective observational study to describe the tolerability of Gilenya (Fingolimod) at the start of treatment in routine clinical practice. I study MS Right,
-
DISTRICT ATTORNEY:
Novartis Pharmaceutica SA
-
TYPE E:
EPA
- Parkinson's disease in our area
- Psychiatric pathology in neurological diseases
- Bilingualism in dementia, stroke and movement disorders
- Multiple Sclerosis: treatment and quality of life
- Cognitive and fluid biomarkers in neurodegenerative disorders
